ABPI

News and analysis related to the Association of the British Pharmaceutical Industry (ABPI).

News and analysis related to the Association of the British Pharmaceutical Industry (ABPI).

Sharing success to unlock the “triple win” of joint working

The fortunes of the NHS and the UK’s life sciences industry are intertwined, with each sector’s success or

Share

X

Sharing success to unlock the “triple win” of joint working

https://pharmaphorum.com/r-d/views-analysis-r-d/sharing-success-to-unlock-the-triple-win-of-joint-working/

Making patient involvement meaningful

True public and patient involvement in research needs to be more than just a box ticking exercise –

Share

X

Making patient involvement meaningful

https://pharmaphorum.com/views-analysis-patients/making-patient-involvement-meaningful/

Digital health isn’t about big data – it’s about people

From training a new generation of data scientists to overcoming privacy concerns, there’s a lot that needs to

Share

X

Digital health isn’t about big data – it’s about people

https://pharmaphorum.com/views-analysis-digital/digital-health-isnt-about-big-data-its-about-people/

Working together to embed public involvement in research

Amanda Barrell speaks to the ABPI deputy chief scientific officer Sheuli Porkess and the NIHR’s Simon Denegri at the

Share

X

Working together to embed public involvement in research

https://pharmaphorum.com/views-analysis-patients/abpi-working-together-to-embed-public-involvement-in-research/

Are your internal processes drowning out the patient voice?

Greater patient involvement is among the stated aims of the ABPI, so why do companies up and down

Share

X

Are your internal processes drowning out the patient voice?

https://pharmaphorum.com/views-analysis-patients/internal-processes-drowning-patient-voice/

UK pharma negotiating choppy seas during Brexit, says ABPI’s outgoing president Nordkamp

pharmaphorum caught up with Erik Nordkamp, outgoing president of the Association of the British Pharmaceutical Industry (ABPI), who

Share

X

UK pharma negotiating choppy seas during Brexit, says ABPI’s outgoing president Nordkamp

https://pharmaphorum.com/views-analysis-market-access/uk-pharma-negotiating-choppy-seas-during-brexit-says-abpis-outgoing-president-nordkamp/

Pharma’s apprentice army is sculpting the future

A skills gap has been threatening to knock the shine off the UK biotechnology sector’s sparkling reputation for

Share

X

Pharma’s apprentice army is sculpting the future

https://pharmaphorum.com/r-d/views-analysis-r-d/pharmas-apprentice-army-is-sculpting-the-future/

 

The 2nd Life Sciences Sector Deal and the NHS 10 Year Plan

Overview Brexit uncertainty isn’t going away any time soon – but it’s important to remember that the UK

Share

X

The 2nd Life Sciences Sector Deal and the NHS 10 Year Plan

https://pharmaphorum.com/market-access-2/the-2nd-life-sciences-sector-deal-and-the-nhs-10-year-plan/

New UK drug pricing deal promises faster medicines access

The UK government has reached a new five-year medicines pricing deal with the pharma industry to replace the

Share

X

New UK drug pricing deal promises faster medicines access

https://pharmaphorum.com/news/new-uk-drug-pricing-deal-promises-faster-medicines-access/